nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitazoxanide—Acetylsalicylic acid—AKR1C1—uterine cancer	0.0354	0.658	CrCbGaD
Nitazoxanide—Acetylsalicylic acid—TP53—uterine cancer	0.0184	0.343	CrCbGaD
Nitazoxanide—Alanine aminotransferase increased—Progesterone—uterine cancer	0.00892	0.00943	CcSEcCtD
Nitazoxanide—Blood creatinine increased—Medroxyprogesterone Acetate—uterine cancer	0.00858	0.00907	CcSEcCtD
Nitazoxanide—Dysuria—Progesterone—uterine cancer	0.00817	0.00864	CcSEcCtD
Nitazoxanide—Pain—Carboplatin—uterine cancer	0.00809	0.00855	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Medroxyprogesterone Acetate—uterine cancer	0.00808	0.00854	CcSEcCtD
Nitazoxanide—Influenza—Medroxyprogesterone Acetate—uterine cancer	0.00792	0.00837	CcSEcCtD
Nitazoxanide—Body temperature increased—Carboplatin—uterine cancer	0.00748	0.0079	CcSEcCtD
Nitazoxanide—Dysuria—Medroxyprogesterone Acetate—uterine cancer	0.00741	0.00783	CcSEcCtD
Nitazoxanide—Rhinitis—Progesterone—uterine cancer	0.00701	0.00741	CcSEcCtD
Nitazoxanide—Pharyngitis—Progesterone—uterine cancer	0.00694	0.00734	CcSEcCtD
Nitazoxanide—Epistaxis—Medroxyprogesterone Acetate—uterine cancer	0.00666	0.00704	CcSEcCtD
Nitazoxanide—Pelvic pain—Epirubicin—uterine cancer	0.00657	0.00694	CcSEcCtD
Nitazoxanide—Pharyngitis—Medroxyprogesterone Acetate—uterine cancer	0.00629	0.00665	CcSEcCtD
Nitazoxanide—Pelvic pain—Doxorubicin—uterine cancer	0.00608	0.00642	CcSEcCtD
Nitazoxanide—Flatulence—Progesterone—uterine cancer	0.006	0.00634	CcSEcCtD
Nitazoxanide—Back pain—Progesterone—uterine cancer	0.00589	0.00623	CcSEcCtD
Nitazoxanide—Muscle spasms—Progesterone—uterine cancer	0.00585	0.00619	CcSEcCtD
Nitazoxanide—Tremor—Progesterone—uterine cancer	0.00571	0.00603	CcSEcCtD
Nitazoxanide—Chills—Medroxyprogesterone Acetate—uterine cancer	0.00569	0.00601	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Progesterone—uterine cancer	0.00565	0.00597	CcSEcCtD
Nitazoxanide—Lung disorder—Epirubicin—uterine cancer	0.00564	0.00596	CcSEcCtD
Nitazoxanide—Anaemia—Progesterone—uterine cancer	0.00563	0.00595	CcSEcCtD
Nitazoxanide—Malaise—Progesterone—uterine cancer	0.00549	0.0058	CcSEcCtD
Nitazoxanide—Syncope—Progesterone—uterine cancer	0.00546	0.00577	CcSEcCtD
Nitazoxanide—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.00544	0.00575	CcSEcCtD
Nitazoxanide—Loss of consciousness—Progesterone—uterine cancer	0.00535	0.00566	CcSEcCtD
Nitazoxanide—Back pain—Medroxyprogesterone Acetate—uterine cancer	0.00534	0.00564	CcSEcCtD
Nitazoxanide—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.00531	0.00561	CcSEcCtD
Nitazoxanide—Hypertension—Progesterone—uterine cancer	0.00526	0.00556	CcSEcCtD
Nitazoxanide—Lung disorder—Doxorubicin—uterine cancer	0.00522	0.00552	CcSEcCtD
Nitazoxanide—Myalgia—Progesterone—uterine cancer	0.00518	0.00548	CcSEcCtD
Nitazoxanide—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.00517	0.00546	CcSEcCtD
Nitazoxanide—Discomfort—Progesterone—uterine cancer	0.00512	0.00541	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.00512	0.00541	CcSEcCtD
Nitazoxanide—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.0051	0.00539	CcSEcCtD
Nitazoxanide—Dry mouth—Progesterone—uterine cancer	0.00507	0.00536	CcSEcCtD
Nitazoxanide—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.00498	0.00526	CcSEcCtD
Nitazoxanide—Oedema—Progesterone—uterine cancer	0.00497	0.00525	CcSEcCtD
Nitazoxanide—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00495	0.00523	CcSEcCtD
Nitazoxanide—Infection—Progesterone—uterine cancer	0.00494	0.00522	CcSEcCtD
Nitazoxanide—Pharyngitis—Dactinomycin—uterine cancer	0.00491	0.00519	CcSEcCtD
Nitazoxanide—Shock—Progesterone—uterine cancer	0.00489	0.00517	CcSEcCtD
Nitazoxanide—Tachycardia—Progesterone—uterine cancer	0.00485	0.00513	CcSEcCtD
Nitazoxanide—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00485	0.00513	CcSEcCtD
Nitazoxanide—Anorexia—Progesterone—uterine cancer	0.00474	0.00501	CcSEcCtD
Nitazoxanide—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.0047	0.00497	CcSEcCtD
Nitazoxanide—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00464	0.00491	CcSEcCtD
Nitazoxanide—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.00459	0.00486	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Etoposide—uterine cancer	0.00456	0.00482	CcSEcCtD
Nitazoxanide—Amenorrhoea—Epirubicin—uterine cancer	0.00455	0.0048	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Progesterone—uterine cancer	0.00453	0.00479	CcSEcCtD
Nitazoxanide—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.0045	0.00476	CcSEcCtD
Nitazoxanide—Insomnia—Progesterone—uterine cancer	0.0045	0.00475	CcSEcCtD
Nitazoxanide—Infection—Medroxyprogesterone Acetate—uterine cancer	0.00447	0.00473	CcSEcCtD
Nitazoxanide—Chills—Dactinomycin—uterine cancer	0.00444	0.00469	CcSEcCtD
Nitazoxanide—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00443	0.00468	CcSEcCtD
Nitazoxanide—Somnolence—Progesterone—uterine cancer	0.00442	0.00467	CcSEcCtD
Nitazoxanide—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.0044	0.00465	CcSEcCtD
Nitazoxanide—Dyspepsia—Progesterone—uterine cancer	0.00437	0.00462	CcSEcCtD
Nitazoxanide—Decreased appetite—Progesterone—uterine cancer	0.00432	0.00457	CcSEcCtD
Nitazoxanide—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00429	0.00454	CcSEcCtD
Nitazoxanide—Constipation—Progesterone—uterine cancer	0.00425	0.00449	CcSEcCtD
Nitazoxanide—Pain—Progesterone—uterine cancer	0.00425	0.00449	CcSEcCtD
Nitazoxanide—Amenorrhoea—Doxorubicin—uterine cancer	0.00421	0.00445	CcSEcCtD
Nitazoxanide—Creatinine increased—Epirubicin—uterine cancer	0.0042	0.00444	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.0041	0.00434	CcSEcCtD
Nitazoxanide—Feeling abnormal—Progesterone—uterine cancer	0.0041	0.00433	CcSEcCtD
Nitazoxanide—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00407	0.0043	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Progesterone—uterine cancer	0.00406	0.0043	CcSEcCtD
Nitazoxanide—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.004	0.00423	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Dactinomycin—uterine cancer	0.00399	0.00422	CcSEcCtD
Nitazoxanide—Anaemia—Dactinomycin—uterine cancer	0.00398	0.0042	CcSEcCtD
Nitazoxanide—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00396	0.00419	CcSEcCtD
Nitazoxanide—Body temperature increased—Progesterone—uterine cancer	0.00393	0.00415	CcSEcCtD
Nitazoxanide—Abdominal pain—Progesterone—uterine cancer	0.00393	0.00415	CcSEcCtD
Nitazoxanide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.00391	0.00414	CcSEcCtD
Nitazoxanide—Creatinine increased—Doxorubicin—uterine cancer	0.00388	0.0041	CcSEcCtD
Nitazoxanide—Malaise—Dactinomycin—uterine cancer	0.00388	0.0041	CcSEcCtD
Nitazoxanide—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00385	0.00407	CcSEcCtD
Nitazoxanide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00371	0.00392	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00368	0.00389	CcSEcCtD
Nitazoxanide—Cramps of lower extremities—Epirubicin—uterine cancer	0.00367	0.00388	CcSEcCtD
Nitazoxanide—Myalgia—Dactinomycin—uterine cancer	0.00366	0.00387	CcSEcCtD
Nitazoxanide—Hypersensitivity—Progesterone—uterine cancer	0.00366	0.00387	CcSEcCtD
Nitazoxanide—Discomfort—Dactinomycin—uterine cancer	0.00362	0.00383	CcSEcCtD
Nitazoxanide—Asthenia—Progesterone—uterine cancer	0.00357	0.00377	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Etoposide—uterine cancer	0.00356	0.00376	CcSEcCtD
Nitazoxanide—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00356	0.00376	CcSEcCtD
Nitazoxanide—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00356	0.00376	CcSEcCtD
Nitazoxanide—Pruritus—Progesterone—uterine cancer	0.00352	0.00372	CcSEcCtD
Nitazoxanide—Oedema—Dactinomycin—uterine cancer	0.00351	0.00371	CcSEcCtD
Nitazoxanide—Infection—Dactinomycin—uterine cancer	0.00349	0.00369	CcSEcCtD
Nitazoxanide—Diarrhoea—Progesterone—uterine cancer	0.0034	0.00359	CcSEcCtD
Nitazoxanide—Cramps of lower extremities—Doxorubicin—uterine cancer	0.0034	0.00359	CcSEcCtD
Nitazoxanide—Anorexia—Dactinomycin—uterine cancer	0.00335	0.00354	CcSEcCtD
Nitazoxanide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.00332	0.00351	CcSEcCtD
Nitazoxanide—Dizziness—Progesterone—uterine cancer	0.00329	0.00347	CcSEcCtD
Nitazoxanide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00323	0.00341	CcSEcCtD
Nitazoxanide—Chills—Etoposide—uterine cancer	0.00321	0.00339	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.0032	0.00338	CcSEcCtD
Nitazoxanide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00319	0.00337	CcSEcCtD
Nitazoxanide—Vomiting—Progesterone—uterine cancer	0.00316	0.00334	CcSEcCtD
Nitazoxanide—Rash—Progesterone—uterine cancer	0.00313	0.00331	CcSEcCtD
Nitazoxanide—Dermatitis—Progesterone—uterine cancer	0.00313	0.00331	CcSEcCtD
Nitazoxanide—Headache—Progesterone—uterine cancer	0.00311	0.00329	CcSEcCtD
Nitazoxanide—Increased appetite—Epirubicin—uterine cancer	0.00309	0.00326	CcSEcCtD
Nitazoxanide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00308	0.00326	CcSEcCtD
Nitazoxanide—Decreased appetite—Dactinomycin—uterine cancer	0.00305	0.00323	CcSEcCtD
Nitazoxanide—Back pain—Etoposide—uterine cancer	0.00301	0.00318	CcSEcCtD
Nitazoxanide—Pain—Dactinomycin—uterine cancer	0.003	0.00317	CcSEcCtD
Nitazoxanide—Muscle spasms—Etoposide—uterine cancer	0.00299	0.00317	CcSEcCtD
Nitazoxanide—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00298	0.00315	CcSEcCtD
Nitazoxanide—Nausea—Progesterone—uterine cancer	0.00295	0.00312	CcSEcCtD
Nitazoxanide—Feeling abnormal—Dactinomycin—uterine cancer	0.00289	0.00306	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Etoposide—uterine cancer	0.00289	0.00305	CcSEcCtD
Nitazoxanide—Anaemia—Etoposide—uterine cancer	0.00288	0.00304	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00287	0.00304	CcSEcCtD
Nitazoxanide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00286	0.00303	CcSEcCtD
Nitazoxanide—Increased appetite—Doxorubicin—uterine cancer	0.00286	0.00302	CcSEcCtD
Nitazoxanide—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00284	0.003	CcSEcCtD
Nitazoxanide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00284	0.003	CcSEcCtD
Nitazoxanide—Headache—Medroxyprogesterone Acetate—uterine cancer	0.00282	0.00298	CcSEcCtD
Nitazoxanide—Malaise—Etoposide—uterine cancer	0.00281	0.00297	CcSEcCtD
Nitazoxanide—Body temperature increased—Dactinomycin—uterine cancer	0.00278	0.00293	CcSEcCtD
Nitazoxanide—Abdominal pain—Dactinomycin—uterine cancer	0.00278	0.00293	CcSEcCtD
Nitazoxanide—Loss of consciousness—Etoposide—uterine cancer	0.00274	0.00289	CcSEcCtD
Nitazoxanide—Blood creatinine increased—Epirubicin—uterine cancer	0.00272	0.00287	CcSEcCtD
Nitazoxanide—Hypertension—Etoposide—uterine cancer	0.00269	0.00284	CcSEcCtD
Nitazoxanide—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00267	0.00283	CcSEcCtD
Nitazoxanide—Discomfort—Etoposide—uterine cancer	0.00262	0.00277	CcSEcCtD
Nitazoxanide—Hypersensitivity—Dactinomycin—uterine cancer	0.00259	0.00274	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.00256	0.0027	CcSEcCtD
Nitazoxanide—Infection—Etoposide—uterine cancer	0.00253	0.00267	CcSEcCtD
Nitazoxanide—Asthenia—Dactinomycin—uterine cancer	0.00252	0.00266	CcSEcCtD
Nitazoxanide—Blood creatinine increased—Doxorubicin—uterine cancer	0.00251	0.00266	CcSEcCtD
Nitazoxanide—Influenza—Epirubicin—uterine cancer	0.00251	0.00265	CcSEcCtD
Nitazoxanide—Tachycardia—Etoposide—uterine cancer	0.00248	0.00262	CcSEcCtD
Nitazoxanide—Anorexia—Etoposide—uterine cancer	0.00242	0.00256	CcSEcCtD
Nitazoxanide—Diarrhoea—Dactinomycin—uterine cancer	0.0024	0.00254	CcSEcCtD
Nitazoxanide—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.00237	0.0025	CcSEcCtD
Nitazoxanide—Dysuria—Epirubicin—uterine cancer	0.00234	0.00248	CcSEcCtD
Nitazoxanide—Influenza—Doxorubicin—uterine cancer	0.00232	0.00245	CcSEcCtD
Nitazoxanide—Somnolence—Etoposide—uterine cancer	0.00226	0.00239	CcSEcCtD
Nitazoxanide—Vomiting—Dactinomycin—uterine cancer	0.00223	0.00236	CcSEcCtD
Nitazoxanide—Rash—Dactinomycin—uterine cancer	0.00221	0.00234	CcSEcCtD
Nitazoxanide—Decreased appetite—Etoposide—uterine cancer	0.00221	0.00234	CcSEcCtD
Nitazoxanide—Constipation—Etoposide—uterine cancer	0.00217	0.0023	CcSEcCtD
Nitazoxanide—Pain—Etoposide—uterine cancer	0.00217	0.0023	CcSEcCtD
Nitazoxanide—Dysuria—Doxorubicin—uterine cancer	0.00217	0.00229	CcSEcCtD
Nitazoxanide—Epistaxis—Epirubicin—uterine cancer	0.00211	0.00223	CcSEcCtD
Nitazoxanide—Feeling abnormal—Etoposide—uterine cancer	0.0021	0.00221	CcSEcCtD
Nitazoxanide—Nausea—Dactinomycin—uterine cancer	0.00209	0.00221	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Etoposide—uterine cancer	0.00208	0.0022	CcSEcCtD
Nitazoxanide—Rhinitis—Epirubicin—uterine cancer	0.00201	0.00213	CcSEcCtD
Nitazoxanide—Body temperature increased—Etoposide—uterine cancer	0.00201	0.00212	CcSEcCtD
Nitazoxanide—Abdominal pain—Etoposide—uterine cancer	0.00201	0.00212	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Epirubicin—uterine cancer	0.002	0.00211	CcSEcCtD
Nitazoxanide—Pharyngitis—Epirubicin—uterine cancer	0.00199	0.0021	CcSEcCtD
Nitazoxanide—Epistaxis—Doxorubicin—uterine cancer	0.00195	0.00206	CcSEcCtD
Nitazoxanide—Hypersensitivity—Etoposide—uterine cancer	0.00187	0.00198	CcSEcCtD
Nitazoxanide—Rhinitis—Doxorubicin—uterine cancer	0.00186	0.00197	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Doxorubicin—uterine cancer	0.00185	0.00195	CcSEcCtD
Nitazoxanide—Pharyngitis—Doxorubicin—uterine cancer	0.00184	0.00195	CcSEcCtD
Nitazoxanide—Asthenia—Etoposide—uterine cancer	0.00182	0.00193	CcSEcCtD
Nitazoxanide—Chills—Epirubicin—uterine cancer	0.0018	0.0019	CcSEcCtD
Nitazoxanide—Pruritus—Etoposide—uterine cancer	0.0018	0.0019	CcSEcCtD
Nitazoxanide—Diarrhoea—Etoposide—uterine cancer	0.00174	0.00184	CcSEcCtD
Nitazoxanide—Flatulence—Epirubicin—uterine cancer	0.00172	0.00182	CcSEcCtD
Nitazoxanide—Back pain—Epirubicin—uterine cancer	0.00169	0.00179	CcSEcCtD
Nitazoxanide—Dizziness—Etoposide—uterine cancer	0.00168	0.00178	CcSEcCtD
Nitazoxanide—Muscle spasms—Epirubicin—uterine cancer	0.00168	0.00177	CcSEcCtD
Nitazoxanide—Chills—Doxorubicin—uterine cancer	0.00167	0.00176	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Epirubicin—uterine cancer	0.00162	0.00171	CcSEcCtD
Nitazoxanide—Vomiting—Etoposide—uterine cancer	0.00162	0.00171	CcSEcCtD
Nitazoxanide—Anaemia—Epirubicin—uterine cancer	0.00161	0.00171	CcSEcCtD
Nitazoxanide—Rash—Etoposide—uterine cancer	0.0016	0.00169	CcSEcCtD
Nitazoxanide—Dermatitis—Etoposide—uterine cancer	0.0016	0.00169	CcSEcCtD
Nitazoxanide—Headache—Etoposide—uterine cancer	0.00159	0.00168	CcSEcCtD
Nitazoxanide—Flatulence—Doxorubicin—uterine cancer	0.00159	0.00168	CcSEcCtD
Nitazoxanide—Malaise—Epirubicin—uterine cancer	0.00157	0.00166	CcSEcCtD
Nitazoxanide—Syncope—Epirubicin—uterine cancer	0.00157	0.00166	CcSEcCtD
Nitazoxanide—Back pain—Doxorubicin—uterine cancer	0.00156	0.00165	CcSEcCtD
Nitazoxanide—Muscle spasms—Doxorubicin—uterine cancer	0.00155	0.00164	CcSEcCtD
Nitazoxanide—Loss of consciousness—Epirubicin—uterine cancer	0.00153	0.00162	CcSEcCtD
Nitazoxanide—Nausea—Etoposide—uterine cancer	0.00151	0.0016	CcSEcCtD
Nitazoxanide—Hypertension—Epirubicin—uterine cancer	0.00151	0.00159	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Doxorubicin—uterine cancer	0.0015	0.00158	CcSEcCtD
Nitazoxanide—Anaemia—Doxorubicin—uterine cancer	0.00149	0.00158	CcSEcCtD
Nitazoxanide—Myalgia—Epirubicin—uterine cancer	0.00149	0.00157	CcSEcCtD
Nitazoxanide—Discomfort—Epirubicin—uterine cancer	0.00147	0.00155	CcSEcCtD
Nitazoxanide—Malaise—Doxorubicin—uterine cancer	0.00146	0.00154	CcSEcCtD
Nitazoxanide—Dry mouth—Epirubicin—uterine cancer	0.00145	0.00154	CcSEcCtD
Nitazoxanide—Syncope—Doxorubicin—uterine cancer	0.00145	0.00153	CcSEcCtD
Nitazoxanide—Oedema—Epirubicin—uterine cancer	0.00143	0.00151	CcSEcCtD
Nitazoxanide—Loss of consciousness—Doxorubicin—uterine cancer	0.00142	0.0015	CcSEcCtD
Nitazoxanide—Infection—Epirubicin—uterine cancer	0.00142	0.0015	CcSEcCtD
Nitazoxanide—Shock—Epirubicin—uterine cancer	0.0014	0.00148	CcSEcCtD
Nitazoxanide—Hypertension—Doxorubicin—uterine cancer	0.00139	0.00147	CcSEcCtD
Nitazoxanide—Tachycardia—Epirubicin—uterine cancer	0.00139	0.00147	CcSEcCtD
Nitazoxanide—Myalgia—Doxorubicin—uterine cancer	0.00138	0.00145	CcSEcCtD
Nitazoxanide—Discomfort—Doxorubicin—uterine cancer	0.00136	0.00144	CcSEcCtD
Nitazoxanide—Anorexia—Epirubicin—uterine cancer	0.00136	0.00144	CcSEcCtD
Nitazoxanide—Dry mouth—Doxorubicin—uterine cancer	0.00135	0.00142	CcSEcCtD
Nitazoxanide—Oedema—Doxorubicin—uterine cancer	0.00132	0.00139	CcSEcCtD
Nitazoxanide—Infection—Doxorubicin—uterine cancer	0.00131	0.00138	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.0013	0.00137	CcSEcCtD
Nitazoxanide—Shock—Doxorubicin—uterine cancer	0.0013	0.00137	CcSEcCtD
Nitazoxanide—Insomnia—Epirubicin—uterine cancer	0.00129	0.00136	CcSEcCtD
Nitazoxanide—Tachycardia—Doxorubicin—uterine cancer	0.00129	0.00136	CcSEcCtD
Nitazoxanide—Somnolence—Epirubicin—uterine cancer	0.00127	0.00134	CcSEcCtD
Nitazoxanide—Anorexia—Doxorubicin—uterine cancer	0.00126	0.00133	CcSEcCtD
Nitazoxanide—Dyspepsia—Epirubicin—uterine cancer	0.00125	0.00133	CcSEcCtD
Nitazoxanide—Decreased appetite—Epirubicin—uterine cancer	0.00124	0.00131	CcSEcCtD
Nitazoxanide—Pain—Epirubicin—uterine cancer	0.00122	0.00129	CcSEcCtD
Nitazoxanide—Constipation—Epirubicin—uterine cancer	0.00122	0.00129	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.0012	0.00127	CcSEcCtD
Nitazoxanide—Insomnia—Doxorubicin—uterine cancer	0.00119	0.00126	CcSEcCtD
Nitazoxanide—Feeling abnormal—Epirubicin—uterine cancer	0.00117	0.00124	CcSEcCtD
Nitazoxanide—Somnolence—Doxorubicin—uterine cancer	0.00117	0.00124	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Epirubicin—uterine cancer	0.00117	0.00123	CcSEcCtD
Nitazoxanide—Dyspepsia—Doxorubicin—uterine cancer	0.00116	0.00123	CcSEcCtD
Nitazoxanide—Decreased appetite—Doxorubicin—uterine cancer	0.00115	0.00121	CcSEcCtD
Nitazoxanide—Constipation—Doxorubicin—uterine cancer	0.00113	0.00119	CcSEcCtD
Nitazoxanide—Pain—Doxorubicin—uterine cancer	0.00113	0.00119	CcSEcCtD
Nitazoxanide—Abdominal pain—Epirubicin—uterine cancer	0.00113	0.00119	CcSEcCtD
Nitazoxanide—Body temperature increased—Epirubicin—uterine cancer	0.00113	0.00119	CcSEcCtD
Nitazoxanide—Feeling abnormal—Doxorubicin—uterine cancer	0.00109	0.00115	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00108	0.00114	CcSEcCtD
Nitazoxanide—Hypersensitivity—Epirubicin—uterine cancer	0.00105	0.00111	CcSEcCtD
Nitazoxanide—Abdominal pain—Doxorubicin—uterine cancer	0.00104	0.0011	CcSEcCtD
Nitazoxanide—Body temperature increased—Doxorubicin—uterine cancer	0.00104	0.0011	CcSEcCtD
Nitazoxanide—Asthenia—Epirubicin—uterine cancer	0.00102	0.00108	CcSEcCtD
Nitazoxanide—Pruritus—Epirubicin—uterine cancer	0.00101	0.00107	CcSEcCtD
Nitazoxanide—Diarrhoea—Epirubicin—uterine cancer	0.000975	0.00103	CcSEcCtD
Nitazoxanide—Hypersensitivity—Doxorubicin—uterine cancer	0.000972	0.00103	CcSEcCtD
Nitazoxanide—Asthenia—Doxorubicin—uterine cancer	0.000946	0.001	CcSEcCtD
Nitazoxanide—Dizziness—Epirubicin—uterine cancer	0.000942	0.000996	CcSEcCtD
Nitazoxanide—Pruritus—Doxorubicin—uterine cancer	0.000933	0.000986	CcSEcCtD
Nitazoxanide—Vomiting—Epirubicin—uterine cancer	0.000906	0.000958	CcSEcCtD
Nitazoxanide—Diarrhoea—Doxorubicin—uterine cancer	0.000902	0.000954	CcSEcCtD
Nitazoxanide—Rash—Epirubicin—uterine cancer	0.000899	0.00095	CcSEcCtD
Nitazoxanide—Dermatitis—Epirubicin—uterine cancer	0.000898	0.000949	CcSEcCtD
Nitazoxanide—Headache—Epirubicin—uterine cancer	0.000893	0.000944	CcSEcCtD
Nitazoxanide—Dizziness—Doxorubicin—uterine cancer	0.000872	0.000922	CcSEcCtD
Nitazoxanide—Nausea—Epirubicin—uterine cancer	0.000846	0.000895	CcSEcCtD
Nitazoxanide—Vomiting—Doxorubicin—uterine cancer	0.000838	0.000886	CcSEcCtD
Nitazoxanide—Rash—Doxorubicin—uterine cancer	0.000831	0.000879	CcSEcCtD
Nitazoxanide—Dermatitis—Doxorubicin—uterine cancer	0.000831	0.000878	CcSEcCtD
Nitazoxanide—Headache—Doxorubicin—uterine cancer	0.000826	0.000873	CcSEcCtD
Nitazoxanide—Nausea—Doxorubicin—uterine cancer	0.000783	0.000828	CcSEcCtD
